Wietecha LA, Kuca B, Case MG, et al.Phase-3 study (SPARTAN) of Lasmiditan compared to placebo for acute treatment of migraine. EAN 2018; abstract O405.
Ocrelizumab bij relapsing en primair progressieve MS
jan 2017 | Multipele Sclerose
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen